These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15823105)

  • 1. Intraperitoneal hyperthermic chemotherapy in ovarian cancer.
    Gori J; Castaño R; Toziano M; Häbich D; Staringer J; De Quirós DG; Felci N
    Int J Gynecol Cancer; 2005; 15(2):233-9. PubMed ID: 15823105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study.
    Deraco M; Rossi CR; Pennacchioli E; Guadagni S; Somers DC; Santoro N; Raspagliesi F; Kusamura S; Vaglini M
    Tumori; 2001; 87(3):120-6. PubMed ID: 11504363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of intraperitoneal hyperthermic perfusion chemotherapy (IHPC) with intraperitoneal chemotherapy as a treatment modality for persistent ovarian cancer.
    Wydra D; Sawicki S; Ciach K; Marciniak A; Emerich J
    Eur J Gynaecol Oncol; 2007; 28(2):128-30. PubMed ID: 17479675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot.
    van der Vange N; van Goethem AR; Zoetmulder FA; Kaag MM; van de Vaart PJ; ten Bokkel Huinink WW; Beijnen JH
    Eur J Surg Oncol; 2000 Nov; 26(7):663-8. PubMed ID: 11078613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
    Massari R; Barone M; Basilico R; Carella C; Colasante A; De Tursi M; Filippone A; Guetti L; Mani A
    Minerva Chir; 2014 Feb; 69(1):17-26. PubMed ID: 24675243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan.
    Raspagliesi F; Kusamura S; Campos Torres JC; de Souza GA; Ditto A; Zanaboni F; Younan R; Baratti D; Mariani L; Laterza B; Deraco M
    Eur J Surg Oncol; 2006 Aug; 32(6):671-5. PubMed ID: 16621425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraperitoneal hyperthermic perfusion chemotherapy in recurrent ovarian cancer].
    Wydra D; Emerich J
    Ginekol Pol; 2002 Nov; 73(11):1044-7. PubMed ID: 12722397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer.
    Hager ED; Dziambor H; Höhmann D; Mühe N; Strama H
    Int J Gynecol Cancer; 2001; 11 Suppl 1():57-63. PubMed ID: 11489005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma.
    Lentz SS; Miller BE; Kucera GL; Levine EA
    Gynecol Oncol; 2007 Jul; 106(1):207-10. PubMed ID: 17498782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a phase II study.
    Lim MC; Kang S; Choi J; Song YJ; Park S; Seo SS; Park SY
    Ann Surg Oncol; 2009 Apr; 16(4):993-1000. PubMed ID: 19169758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for management of recurrent/relapsed ovarian granulosa cell tumor: a single-center experience.
    Al-Badawi IA; Abu-Zaid A; Azzam A; AlOmar O; AlHusaini H; Amin T
    J Obstet Gynaecol Res; 2014 Sep; 40(9):2066-75. PubMed ID: 25181627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of different chemotherapy approaches for advanced epithelial ovarian cancer].
    Chen YL; Liu YQ; Tang DH; Chu CN
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):110-4. PubMed ID: 18683749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma.
    Helm CW; Randall-Whitis L; Martin RS; Metzinger DS; Gordinier ME; Parker LP; Edwards RP
    Gynecol Oncol; 2007 Apr; 105(1):90-6. PubMed ID: 17173957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma: A Feasibility Study.
    D'Hondt V; Goffin F; Roca L; Dresse D; Leroy C; Kerger J; Cordier L; de Forges H; Veys I; Liberale G
    Int J Gynecol Cancer; 2016 Jun; 26(5):912-7. PubMed ID: 27051055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer.
    Kim JH; Lee JM; Ryu KS; Lee YS; Park YG; Hur SY; Lee KH; Lee SH; Kim SJ
    J Surg Oncol; 2010 Feb; 101(2):149-55. PubMed ID: 20035540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer.
    Gouy S; Ferron G; Glehen O; Bayar A; Marchal F; Pomel C; Quenet F; Bereder JM; Le Deley MC; Morice P
    Gynecol Oncol; 2016 Aug; 142(2):237-42. PubMed ID: 27246305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission.
    Tournigand C; Louvet C; Molitor JL; Fritel X; Dehni N; Sezeur A; Pigné A; Cady J; Milliez J; de Gramont A
    Gynecol Oncol; 2003 Nov; 91(2):341-5. PubMed ID: 14599864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consolidation with intraperitoneal cisplatin in first-line therapy of advanced ovarian cancer.
    Beller U; Speyer J; Colombo N; Sorich J; Wernz J; Hochster H; Zeleniuch-Jacquotte A; Porges R; Beckman EM
    J Clin Oncol; 1991 May; 9(5):809-17. PubMed ID: 2016624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up.
    Shapiro F; Schneider J; Markman M; Reichman BS; Venkatraman E; Barakat R; Almadrones L; Spriggs D
    Gynecol Oncol; 1997 Oct; 67(1):39-45. PubMed ID: 9345354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.